|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
25.11.2025
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
At the Board of Directors meeting held today (01.12.2025), it was resolved to annul the provisions regarding the independent board member candidacy included in the Board resolution dated 25.11.2025, and to re-evaluate the matter within the framework of the minutes of the Corporate Governance Committee meeting dated 01.12.2025 and numbered 2025/08.
Accordingly, the "Independent Board Member Candidates Assessment Report," prepared at the meeting of our Company's Corporate Governance Committee dated 01.12.2025, has been approved by our Board of Directors. It has been resolved to submit the current independent board members, Prof. Dr. İlhan Aksoy and İsmet Turan, to the Capital Markets Board for its approval in accordance with Article 4.3.7 of the Corporate Governance Communiqué.
The résumés of Prof. Dr. İlhan Aksoy and İsmet Turan are enclosed herewith. |
||||||||